AgentZ

CES 2026

WELT Unveils the World’s First “AI-Combo Drug” at CES 2026

WELT, the Samsung spin-off digital‑pharmaceutical company behind the KFDA‑approved and CE‑certified insomnia Digital Therapeutics ‘SleepQ’, announced today that it has been named a CES 2026 Innovation Awards Honoree for its groundbreaking AI agent, ‘AgentZ’. AgentZ transforms everyday generic sleep medications into personalized, AI‑enhanced precision therapies—without altering the chemical formulation of the pill. By scanning a QR code placed on medication…